Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Racz

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Pharmaceutics|June 28, 2023
Rewiring Drug Research and Development through Human Data-Driven Discovery (HD<sup>3</sup>)David B Jackson, Rebecca Racz, Sarah Kim, et al.
BMC Bioinformatics|May 1, 2020
Predicting potential adverse events using safety data from marketed drugsChathuri Daluwatte, Peter Schotland, David G Strauss, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 25, 2018
Target-Adverse Event Profiles to Augment Pharmacovigilance: A Pilot Study With Six New Molecular EntitiesPeter Schotland, Rebecca Racz, David Jackson, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 7, 2022
A network paradigm predicts drug synergistic effects using downstream protein-protein interactionsJennifer L Wilson, Ethan Steinberg, Rebecca Racz, et al.
Chemical Research in Toxicology|November 13, 2024
Quantitative Structure-Activity Relationship Models to Predict Cardiac Adverse EffectsZhongyu Mou, Patra Volarath, Rebecca Racz, et al.
Journal of Pharmacological and Toxicological Methods|July 6, 2021
Aggregation and analysis of secondary pharmacology data from investigational new drug submissions at the US Food and Drug AdministrationAndrew Dodson, Kevin Mi, Daniel P Russo, et al.
BMC Bioinformatics|November 2, 2023
Deep learning-enabled natural language processing to identify directional pharmacokinetic drug-drug interactionsJoel Zirkle, Xiaomei Han, Rebecca Racz, et al.
Plos Computational Biology|December 12, 2018
PathFX provides mechanistic insights into drug efficacy and safety for regulatory review and therapeutic developmentJennifer L Wilson, Rebecca Racz, Tianyun Liu, et al.
Clinical Pharmacology and Therapeutics|October 22, 2020
Target Adverse Event Profiles for Predictive Safety in the Postmarket SettingPeter Schotland, Rebecca Racz, David B Jackson, et al.
Clinical Pharmacology and Therapeutics|November 19, 2025
Pediatric Developmental Safety Assessment: Are We Ready for the Next Thalidomide?Gilbert J Burckart, Susan M Abdel-Rahman, Gelareh Abulwerdi, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Pharmaceutics|June 28, 2023
Rewiring Drug Research and Development through Human Data-Driven Discovery (HD<sup>3</sup>)David B Jackson, Rebecca Racz, Sarah Kim, et al.
BMC Bioinformatics|May 1, 2020
Predicting potential adverse events using safety data from marketed drugsChathuri Daluwatte, Peter Schotland, David G Strauss, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 25, 2018
Target-Adverse Event Profiles to Augment Pharmacovigilance: A Pilot Study With Six New Molecular EntitiesPeter Schotland, Rebecca Racz, David Jackson, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 7, 2022
A network paradigm predicts drug synergistic effects using downstream protein-protein interactionsJennifer L Wilson, Ethan Steinberg, Rebecca Racz, et al.
Chemical Research in Toxicology|November 13, 2024
Quantitative Structure-Activity Relationship Models to Predict Cardiac Adverse EffectsZhongyu Mou, Patra Volarath, Rebecca Racz, et al.
Journal of Pharmacological and Toxicological Methods|July 6, 2021
Aggregation and analysis of secondary pharmacology data from investigational new drug submissions at the US Food and Drug AdministrationAndrew Dodson, Kevin Mi, Daniel P Russo, et al.
BMC Bioinformatics|November 2, 2023
Deep learning-enabled natural language processing to identify directional pharmacokinetic drug-drug interactionsJoel Zirkle, Xiaomei Han, Rebecca Racz, et al.
Plos Computational Biology|December 12, 2018
PathFX provides mechanistic insights into drug efficacy and safety for regulatory review and therapeutic developmentJennifer L Wilson, Rebecca Racz, Tianyun Liu, et al.
Clinical Pharmacology and Therapeutics|October 22, 2020
Target Adverse Event Profiles for Predictive Safety in the Postmarket SettingPeter Schotland, Rebecca Racz, David B Jackson, et al.
Clinical Pharmacology and Therapeutics|November 19, 2025
Pediatric Developmental Safety Assessment: Are We Ready for the Next Thalidomide?Gilbert J Burckart, Susan M Abdel-Rahman, Gelareh Abulwerdi, et al.
Pageof 4